Testing a Human Antimicrobial RNase Chimera Against Bacterial Resistance
The emergence of bacterial resistance to the most commonly used antibiotics encourages the design of novel antimicrobial drugs. Antimicrobial proteins and peptides (AMPs) are the key players in host innate immunity. They exert a rapid and multifaceted action that reduces the development of bacterial...
Main Authors: | Guillem Prats-Ejarque, Jiarui Li, Fatima Ait-Ichou, Helena Lorente, Ester Boix |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2019.01357/full |
Similar Items
-
Structure-Based Design of an RNase Chimera for Antimicrobial Therapy
by: Guillem Prats-Ejarque, et al.
Published: (2021-12-01) -
A Common Polymorphism in <i>RNASE6</i> Impacts Its Antimicrobial Activity toward Uropathogenic <i>Escherichia coli</i>
by: Raul Anguita, et al.
Published: (2024-01-01) -
Exploring the RNase A scaffold to combine catalytic and antimicrobial activities. Structural characterization of RNase 3/1 chimeras
by: Pablo Fernández-Millán, et al.
Published: (2022-09-01) -
Evolutionary Trends in RNA Base Selectivity Within the RNase A Superfamily
by: Guillem Prats-Ejarque, et al.
Published: (2019-10-01) -
Antimicrobial properties of tomato juice and peptides against typhoidal Salmonella
by: Ryan S. Kwon, et al.
Published: (2024-03-01)